Morgan Stanley »

Aprea Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $122k 30k 4.08
2024-03-31 $179k 27k 6.69
2023-12-31 $81k 17k 4.70
2023-09-30 $61k 15k 4.17
2023-06-30 $48k 15k 3.15